Genetic testing for cancer predisposition and implications for nursing practice: Narrative review

Journal of Advanced Nursing

Volumn 66, Issue 4, 2010, Pages 710-737

  Bancroft, Elizabeth Kathryn ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Cancer genetics; Cancer predisposition; Cancer risk; Genetic counselling; Genetic testing; Narrative review; Nursing practice

Indexed keywords

ATTITUDE TO HEALTH; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; NEOPLASM; NURSING PROCESS; PSYCHOLOGICAL ASPECT; REVIEW; UTILIZATION REVIEW;

ATTITUDE TO HEALTH; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; NEOPLASMS; NURSING PROCESS;

EID: 77951607810     PISSN: 03092402     EISSN: 13652648     Source Type: Journal    
DOI: 10.1111/j.1365-2648.2010.05286.x     Document Type: Review

References (102)

1. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. International Journal of Cancer 1995, 64:430-433.
2. Aktan-Collan K, Mecklin JP, Jarvinen H, Nystrom-Lahti M, Peltomaki P, Soderling I, Uutela A, de la Chapelle A, Kaariainen H. Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. International Journal of Cancer 2000, 89:44-50.
3. Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, Kaariainen H. Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. International Journal of Cancer 2001, 93:608-611.
4. Policy Statement Update: Genetic Testing for Cancer Susceptibility 2003, http://www.jco.org/cgi/content/abstract/JCO.2003.03.189v1?ck=nck, Retrieved from on 10 July 2009
5. Andrews L, Meiser B, Apicella C, Tucker K. Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study. Genetic Testing 2004, 8:240-247.
6. Andrykowski MA, Munn RK, Studts JL. Interest in learning of personal genetic risk for cancer: a general population survey. Preventive Medicine 1996, 25:527-536.
7. 2008, http://www.abi.org.uk/, Retrieved from on 8 August 2008
8. Billings P, Beckwith J. Genetic testing in the workplace: a view from the USA. Trends in Genetics 1992, 8:198-202.
9. Bonadona V, Saltel P, Desseigne F, Mignotte H, Saurin JC, Wang Q, Sinilnikova O, Giraud S, Freyer G, Plauchu H, Puisieux A, Lasset C. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. Cancer Epidemiology, Biomarkers and Prevention 2002, 11:97-104.
10. Botkin JR, Smith KR, Croyle RT, Baty BJ, Wylie JE, Dutson D, Chan A, Hamann HA, Lerman C, McDonald J, Venne V, Ward JH, Lyon E. Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. American Journal of Medical Genetics A 2003, 118:201-209.
11. Brain K, Gray J, Norman P, Parsons E, Clarke A, Rogers C, Mansel R, Harper P. Why do women attend familial breast cancer clinics? Journal of Medical Genetics 2000, 37:197-202.
12. Bratt O, Kristoffersson U, Lundgren R, Olsson H. Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing. Urology 1997, 50:360-365.
13. Bratt O, Damber JE, Emanuelsson M, Kristoffersson U, Lundgren R, Olsson H, Gronberg H. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. European Journal of Cancer 2000, 36:235-241.
14. Cancer risks in BRCA2 mutation carriers. Journal of the National Cancer Institute 1999, 91:1310-1316.
15. Bruno M, Tommasi S, Stea B, Quaranta M, Schittulli F, Mastropasqua A, Distante A, Di Paola L, Paradiso A. Awareness of breast cancer genetics and interest in predictive genetic testing: a survey of a southern Italian population. Annals of Oncology 2004, 15:I48-I54.
16. Burke W. Genetic testing in primary care. Annual Review of Genomics and Human Genetics 2004, 5:1-14.
17. Calzone KA. Genetic predisposition testing: clinical implications for oncology nurses. Oncology Nurses Forum 1997, 24:712-718.
18. Cappelli M, Surh L, Humphreys L, Verma S, Logan D, Hunter A, Allanson J. Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clinical Genetics 1999, 55:419-430.
19. Chaliki H, Loader S, Levenkron JC, Logan-Young W, Hall WJ, Rowley PT. Women's receptivity to testing for a genetic susceptibility to breast cancer. American Journal of Public Health 1995, 85:1133-1135.
20. Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, Legius E. Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact. Patient Education and Counselling 2004, 55:265-274.
21. Codori AM, Petersen GM, Miglioretti DL, Larkin EK, Bushey MT, Young C, Brensinger JD, Johnson K, Bacon JA, Booker SV. Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiology, Biomarkers and Prevention 1999, 8:345-351.
22. Collins JA, Fauser BCJM. Balancing the strengths of systematic and narrative reviews. Human Reproduction Update 2005, 11:103-104.
23. Cormier L, Valeri A, Azzouzi R, Fournier G, Cussenot O, Berthon P, Guillemin F, Mangin P. Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing. Prostate 2002, 51:276-285.
24. Croyle RT, Lerman C. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Preventive Medicine 1993, 22:284-292.
25. Croyle RT, Smith KR, Botkin JR, Baty B, Nash J. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychology 1997, 16:63-72.
26. Davison C, Macintyre S, Smith GD. The potential social impact of predictive genetic testing for susceptibility to common chronic diseases: a review and proposed research agenda. Sociology of Health and Illness 1994, 16:340-371.
27. The NHS Cancer Plan: A Plan for Investment, a Plan for Reform 2000, Department of Health, London, UK
28. Our Inheritance, our Future: Realising the Potential of Genetics in the NHS 2003, Department of Health, London, UK
29. Diefenbach MA, Schnoll RA, Miller SM, Brower L. Genetic testing for prostate cancer. Willingness and predictors of interest. Cancer Practice 2000, 8:82-86.
30. van Dooren S, Seynaeve C, Rijnsburger A, Duivenvoorden H, Essink-Bot ML, Bartels C, Klijn J, Koning H, Tibben A. The impact of having relatives affected with breast cancer on psychological distress in women at increased risk for hereditary breast cancer. Breast Cancer Research and Treatment 2005, 89:75-80.
31. Durfy SJ, Bowen DJ, McTiernan A, Sporleder J, Burke W. Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiology, Biomarkers and Prevention 1999, 8:369-375.
32. Easton DF, Eeles RA. Genome-wide association studies in cancer. Human Molecular Genetics 2008, 17:R109-R115.
33. Eeles RA. Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research 2000, 2:283-290.
34. Genetic Predisposition to Cancer 2004, Eeles RAEaston DFPonder BAJEng C. Editors, 2nd edn, Arnold, London, UK
35. Harmonising Genetic Testing Across Europe 2009, http://www.eurogentest.org/, Retrieved from on 10 July 2009
36. Towards Quality Assurance and Harmonisation of Genetic Testing Services in the EU 2003, http://www.jrc.es/home/pages/detail.cfm?prs=1124, Retrieved from on 10 July 2009
37. Forrest K, Simpson SA, Wilson BJ, van Teijlingen ER, McKee L, Haites N, Matthews E. To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clinical Genetics 2003, 64:317-326.
38. Foster C, Watson M, Eeles R, Eccles D, Ashley S, Davidson R, Mackay J, Morrison PJ, Hopwood P, Evans DG. Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up. British Journal of Cancer 2007, 96:718-724.
39. Gaff CL, Clarke AJ, Atkinson P, Sivell S, Elwyn G, Iredale R, Thornton H, Dundon J, Shaw C, Edwards A. Process and outcome in communication of genetic information within families: a systematic review. European Journal of Human Genetics 2007, 10:999-1011.
40. Glanz K, Grove J, Lerman C, Gotay C, Le Marchand L. Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiology, Biomarkers and Prevention 1999, 8:329-336.
41. Hadley DW, Jenkins J, Dimond E, Nakahara K, Grogan L, Liewehr DJ, Steinberg SM, Kirsch I. Genetic counseling and testing in families with hereditary non polyposis colorectal cancer. Archives of Internal Medicine 2003, 163:573-582.
42. Hallowell N, Foster C, Eeles R, Ardern-Jones A, Murday V, Watson M. Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information. Journal of Medical Ethics 2003, 29:74-79.
43. Hallowell N, Foster C, Eeles R, Ardern-Jones A, Watson M. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer. Social Science in Medicine 2004, 59:553-565.
44. Hallowell N, Ardern-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C, Watson M. Men's decision-making about predictive BRCA1/2 testing: the role of family. Journal of Genetic Counselling 2005, 14:207-217.
45. DNA Presymptomatic and Predictive Testing for Genetic Disorders 2002, http://www.hgsa.com.au/, Retrieved from on 10 July 2009
46. Javitt GH, Hudson K. The right prescription for personalized genetic medicine. Personalized Medicine 2007, 4:115-118.
47. Julian-Reynier C, Eisinger F, Chabal F, Aurran Y, Bignon YJ, Nogues C, Machelard M, Maugard C, Vennin P, Sobol H. Cancer genetic clinics: why do women who already have cancer attend? European Journal of Cancer 1998, 34:1549-1553.
48. Julian-Reynier C, Sobol H, Sevilla C, Nogues C, Bourret P. Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network. Psycho-oncology 2000, 9:504-510.
49. Kash KM, Holland JC, Halper MS, Miller DG. Psychological distress and surveillance behaviors of women with a family history of breast cancer. Journal of the National Cancer Institute 1992, 84:24-30.
50. Kinney AY, Choi YA, DeVellis B, Kobetz E, Millikan RC, Sandler RS. Interest in genetic testing among first-degree relatives of colorectal cancer patients. American Journal of Preventive Medicine 2000, 18:249-252.
51. Lango H, Weedon MN. What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice? Journal of Internal Medicine 2008, 263:16-27.
52. Lerman C, Shields AE. Genetic testing for cancer susceptibility: the promise and the pitfalls. Nature Reviews Cancer 2004, 4:235-241.
53. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. Journal of Clinical Oncology 1994, 12:843-850.
54. Lerman C, Marshall J, Audrain J, Gomez-Caminero A. Genetic testing for colon cancer susceptibility: anticipated reactions of patients and challenges to providers. International Journal of Cancer 1996a, 69:58-61.
55. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. Journal of the American Medical Association 1996b, 275:1885-1892.
56. Lerman C, Hughes C, Trock BJ, Myers RE, Main D, Bonney A, Abbaszadegan MR, Harty AE, Franklin BA, Lynch JF, Lynch HT. Genetic testing in families with hereditary non polyposis colon cancer. Journal of the American Medical Association 1999, 281:1618-1622.
57. Lerman C, Hughes C, Croyle RT, Main D, Durham C, Snyder C, Bonney A, Lynch JF, Narod SA, Lynch HT. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Preventive Medicine 2000, 31:75-80.
58. Lerman C, Croyle RT, Tercyak KP, Hamann H. Genetic testing: psychological aspects and implications. Journal of Consultations in Clinical Psychology 2002, 70:784-797.
59. Li Y, Doukas DJ. Health motivation and emotional vigilance in genetic testing for prostate cancer risk. Clinical Genetics 2004, 66:512-516.
60. Liede A, Metcalfe K, Hanna D, Hoodfar E, Snyder C, Durham C, Lynch HT, Narod SA. Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. American Journal of Human Genetics 2000, 67:1494-1504.
61. Lipkus IM, Iden D, Terrenoire J, Feaganes JR. Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer. Cancer Epidemiology, Biomarkers and Prevention 1999, 8:533-539.
62. Loader S, Shields CG, Rowley PT. Impact of genetic testing for breast-ovarian cancer susceptibility. Genetic Testing 2004, 8:1-12.
63. Lodder L, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Duivenvoorden HJ, Tibben A, Wagner A, van der Meer CA, van den Ouweland AM, Niermeijer MF. Psychological impact of receiving a BRCA1/BRCA2 test result. American Journal of Medical Genetics 2001, 98:15-24.
64. Lynch HT, Snyder C, Lynch JF, Karatoprakli P, Trowonou A, Metcalfe K, Narod SA, Gong G. Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. Cancer Genetics and Cytogenetics 2006, 165:91-97.
65. Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT, Seynaeve C, Tilanus-Linthorst MM, Wagner A, Dukel L, Devilee P, van den Ouweland AM, van Geel AN, Klijn JG. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 2000, 355:2015-2020.
66. Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psycho-oncology 2005, 14:1060-1074.
67. Meiser B, Butow P, Barratt A, Suthers G, Smith M, Colley A, Thompson E, Tucker K. Attitudes to genetic testing for breast cancer susceptibility in women at increased risk developing hereditary breast cancer. Journal of Medical Genetics 2000, 37:472-476.
68. Meiser B, Butow P, Friedlander M, Barratt A, Schnieden V, Watson M, Brown J, Tucker K. Psychological impact of genetic testing in women from high-risk breast cancer families. European Journal of Cancer 2002, 38:2025-2031.
69. Meiser B, Collins V, Warren R, Gaff C, St John DJ, Young MA, Harrop K, Brown J, Halliday J. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clinical Genetics 2004, 66:502-511.
70. Miesfeldt S, Jones SM, Cohn W, Lippert M, Haden K, Turner BL, Martin-Fries T, Clark SM. Men's attitudes regarding genetic testing for hereditary prostate cancer risk. Urology 2000, 55:46-50.
71. Myers RE, Hyslop T, Jennings-Dozier K, Wolf TA, Burgh DY, Diehl JA, Lerman C, Chodak GW. Intention to be tested for prostate cancer risk among African-American men. Cancer Epidemiology, Biomarkers and Prevention 2000, 9:1323-1328.
72. Familial Breast Cancer the Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary care (NICE Guideline) 2006, http://www.nice.org.uk, National Institute for Health and Clinical Excellence, Retrieved from on 10 June 2007
73. The social power of genetic information. The Code of Codes 1992, 177-190. Kelves DJHood L. In, eds, Harvard University Press, Cambridge, MA, pp
74. van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, Van Gool AR, Klijn JG, Tibben A. Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing. Annals of Oncology 2006, 17:1090-1095.
75. van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, Van Gool AR, Klijn JG, Riedijk SR, van Dooren S, Tibben A. A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships. Psycho-oncology 2007, 16:320-328.
76. Patenaude AF. The genetic testing of children for cancer susceptibility: ethical, legal, and social issues. Behavioural Sciences and the Law 1996, 14:393-410.
77. Pearson H. Genetic testing for everyone. Nature 2008, 453:570-571.
78. Peterson EA, Milliron KJ, Lewis KE, Goold SD, Merajver SD. Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiology, Biomarkers and Prevention 2002, 11:79-87.
79. Pharoah PD, Antoniou AC, Easton DF, Ponder BA. Polygenes, risk prediction, and targeted prevention of breast cancer. New England Journal of Medicine 2008, 358:2796-2803.
80. Ponder M, Green J. BRCA1 testing: some issues in moving from research to service. Psycho-oncology 1996, 5:223-232.
81. Reichelt JG, Heimdal K, Moller P, Dahl AA. BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample. Family Cancer 2004, 3:21-28.
82. van Roosmalen MS, Stalmeier PF, Verhoef LC, Hoekstra-Weebers JE, Oosterwijk JC, Hoogerbrugge N, Moog U, van Daal WA. Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. American Journal of Medical Genetics A 2004, 124:346-355.
83. Rose AL, Peters N, Shea JA, Armstrong K. Attitudes and misconceptions about predictive genetic testing for cancer risk. Community Genetics 2005, 8:145-151.
84. Sanderson SC, Wardle J, Jarvis MJ, Humphries SE. Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK. Preventive Medicine 2004, 39:458-464.
85. Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J, Ellis N, Hensley M, Boyd J, Borgen P, Norton L, Offit K. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. Journal of Clinical Oncology 2002, 20:1260-1268.
86. Schwartz MD, Lerman C, Miller SM, Daly M, Masny A. Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer. Health Psychology 1995, 14:232-235.
87. Schwartz MD, Peshkin BN, Hughes C, Main D, Isaacs C, Lerman C. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. Journal of Clinical Oncology 2002, 20:514-520.
88. Shaw JS, Bassi KL. Lay attitudes toward genetic testing for susceptibility to inherited diseases. Journal of Health Psychology 2001, 6:405-423.
89. Singer PA, Daar AS. Harnessing genomics and biotechnology to improve global health equity. Science 2001, 294:2289-2290.
90. Smith KR, Croyle RT. Attitudes toward genetic testing for colon cancer risk. American Journal of Public Health 1995, 85:1435-1438.
91. Struewing JP, Lerman C, Kase RG, Giambarresi TR, Tucker MA. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiology, Biomarkers and Prevention 1995, 4:169-173.
92. Tambor ES, Rimer BK, Strigo TS. Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. American Journal of Medical Genetics 1997, 68:43-49.
93. 2008, http://www.genome.gov/Pages/PolicyEthics/GeneticDiscrimination/GINAInfoDoc.pdf, Retrieved from on 20th October 2009
94. 2009, http://www.nchpeg.org, Retrieved from on 10 July 2009
95. 2009, http://www.geneticseducation.nhs.uk, Retrieved from on 10 July 2009
96. Thompson D, Easton DF. Cancer incidence in BRCA1 mutation carriers. Journal of the National Cancer Institute 2002, 94:1358-1365.
97. Watson M, Foster C, Eeles R, Eccles D, Ashley S, Davidson R, Mackay J, Morrison PJ, Hopwood P, Evans DG. Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. British Journal of Cancer 2004, 91:1787-1794.
98. Wellisch DK, Gritz ER, Schain W, Wang HJ, Siau J. Psychological functioning of daughters of breast cancer patients. Part I: Daughters and comparison subjects. Psychosomatics 1991, 32:324-336.
99. Wilson BJ, Forrest K, van Teijlingen ER, McKee L, Haites N, Matthews E, Simpson SA. Family communication about genetic risk: the little that is known. Community Genetics 2004, 7:15-24.
100. Statement of the WHO Expert Consultation on New Developments in Human Genetics 2000, http://www.whqlibdoc.who.int/hq/2000/WHO_HGN_WG_00.3.pdf, Retrieved from on 20th October 2009
101. Statement on Genetics and Medicine 2005, http://www.wma.net/e/policy/g11.htm, Retrieved from on 20th October 2009
102. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Balter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Gronberg H. Cumulative association of five genetic variants with prostate cancer. New England Journal of Medicine 2007, 358:910-919.